Search for Clinical Trial Results
Exanthema - 21 Studies Found
Status | Study |
Recruiting |
Study Name: Severe Cutaneous Adverse Reactions in Thailand Condition:
|
Recruiting |
Study Name: Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases Condition:
|
Completed |
Study Name: Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors Condition: Skin Rash Date: 2008-07-01 Interventions: Procedure: Skin Biopsy of Skin Rash Secondary to EGFRI Use Patients who were treated with lapatinib, cet |
Withdrawn |
Study Name: Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug) Condition: Skin Rash Date: 2011-02-15 Interventions: Drug: Acitretin Acitretin 10 mg by mouth daily Other |
Recruiting |
Study Name: Prevalence of Replication of Human Herpes Virus 6 (HHV6) in Blood and Skin During Exanthemia, in Patients With Hemopathy. Is There a Correlation With the Etiology of the Exanthema? Condition:
Date: 2017-03-31 Interventions: Other: Measurement of the prevalence of the positivity of cutaneous HHV6 quantitative PCR in the cohort studied. |
Recruiting |
Study Name: A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption Condition:
|
Terminated |
Study Name: Vitamin D Supplementation in Polymorphic Light Eruption Condition: Polymorphic Light Eruption Date: 2012-04-26 Interventions:
|
Completed |
Study Name: Calcipotriol and Polymorphic Light Eruption Condition: Polymorphic Light Eruption Date: 2009-03-27 Interventions: Drug: Calcipotriol-containing cream Topical treatment twice a day for 7 days |
Completed |
Study Name: Sunscreen and After-sun-lotion Protection in Polymorphic Light Eruption Condition: Polymorphic Light Eruption Date: 2007-10-24 Interventions:
|
Completed |
Study Name: Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib) Condition:
Date: 2013-05-31 Interventions: Drug: Tetracycline The experimental group will receive tetracycline 250mg every 12 hours for 1 month the |